Abstract
Substantial improvement in cervical disease is seen with initiation of antiretroviral therapy containing a protease inhibitor. HIV infection in women is associated with a high prevalence of human papillomavirus (HPV)-associated cervical disease. Furthermore, the prevalence of squamous intra-epithelial lesions (SIL) appears to increase with progressive immunodeficiency. In this prospective cohort study, French researchers describe the effect of initiating protease …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
